Cargando…

Oral neutrophil quantitation in patients undergoing elective cardiopulmonary bypass

Detalles Bibliográficos
Autores principales:	Wilcox, ME, Perez, P, DosSantos, C, Glogauer, M, Charbonney, E, Duggal, A, Sutherland, S, Rubenfeld, G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3363433/ http://dx.doi.org/10.1186/cc10622

Ejemplares similares

0450. Systemic dysregulation of the angiopoietin-1/2 system in adults undergoing cardiopulmonary bypass (CBP)
por: Charbonney, E, et al.
Publicado: (2014)

Oral neutrophils are an independent marker of the systemic inflammatory response after cardiac bypass
por: Wilcox, Mary Elizabeth, et al.
Publicado: (2014)

Systemic angiopoietin-1/2 dysregulation following cardiopulmonary bypass in adults
por: Charbonney, Emmanuel, et al.
Publicado: (2017)

Hematocrit of 20% versus 25% during normothermic cardiopulmonary bypass for elective coronary artery bypass graft surgery
por: von Heymann, C, et al.
Publicado: (2005)

Safety and effectiveness of different treatment regimes with tranexamic acid in elective cardiopulmonary bypass patients
por: Iribarren, JL, et al.
Publicado: (2011)

The Effect of Conventional and Mini-Invasive Cardiopulmonary Bypass on Neutrophil Activation in Patients Undergoing Coronary Artery Bypass Grafting
por: Kolackova, Martina, et al.
Publicado: (2012)

Impact of antiplatelet therapy and cardiopulmonary bypass on platelet function in patients undergoing coronary artery bypass grafting using multiple electrode aggregometry
por: Gersak, B, et al.
Publicado: (2013)

Fibrinolysis during cardiopulmonary bypass detected with thromboelastography
por: Hájek, R, et al.
Publicado: (2007)

Does cardiopulmonary bypass affect the procalcitonin level?
por: Kalay, F, et al.
Publicado: (2005)

Perioperative changes in plasma brain natriuretic peptide and N-terminal probrain natriuretic peptide in patients undergoing coronary bypass surgery under cardiopulmonary bypass
por: Ciufu, M, et al.
Publicado: (2004)

Macrophage chemoattractant protein 1 and outcome in cardiopulmonary bypass
por: Pereira, KC, et al.
Publicado: (2005)

Influence of amiodarone treatment on inflammation during cardiopulmonary bypass
por: Delle Karth, G, et al.
Publicado: (2005)

Complement activation and excessive bleeding in cardiopulmonary bypass surgery
por: Iribarren, J, et al.
Publicado: (2007)

Ketamine and the coagulation response during and after cardiopulmonary bypass
por: Husedzinovic, I, et al.
Publicado: (2005)

Factors associated with excessive bleeding in cardiopulmonary bypass patients
por: Jimenez Rivera, J, et al.
Publicado: (2006)

Iatrogenic Acute Type A Aortic Dissection following Elective Cardiopulmonary Bypass
por: Huette, Pierre, et al.
Publicado: (2020)

Use of procalcitonin for identification of postoperative complications after coronary artery bypass surgery with cardiopulmonary bypass
por: Baysal, A, et al.
Publicado: (2014)

Evaluation of the results of patients who underwent coronary bypass grafting with or without cardiopulmonary bypass pump
por: Kwinecki, P, et al.
Publicado: (2013)

Intensive insulin therapy does not change the inflammatory response in non-diabetic patients undergoing elective coronary artery bypass grafting
por: Hoedemaekers, C, et al.
Publicado: (2005)

Impact of body mass index on postoperative bleeding in cardiopulmonary bypass
por: Brouard, M, et al.
Publicado: (2007)

Sublingual microcirculation is impaired during cardiopulmonary bypass in cardiac surgery
por: den Uil, C, et al.
Publicado: (2007)

Comparison of neutrophil:lymphocyte ratios following coronary artery bypass surgery with or without cardiopulmonary bypass
por: Aldemir, Mustafa, et al.
Publicado: (2015)

Elective orthopedic and cardiopulmonary bypass surgery causes a reduction in serum endostatin levels
por: Åkerfeldt, Torbjörn, et al.
Publicado: (2014)

Inhibition of neutrophil activity improves cardiac function after cardiopulmonary bypass
por: Abdel-Rahman, Ulf, et al.
Publicado: (2007)

Pulmonary perfusion reduces accumulation of neutrophils in the lung during cardiopulmonary bypass
por: Schlensak, C, et al.
Publicado: (2003)

Increased Circulating Levels of Neutrophil Extracellular Traps During Cardiopulmonary Bypass
por: Beaubien-Souligny, William, et al.
Publicado: (2019)

Microvascular effects of pulsatile versus nonpulsatile perfusion during cardiopulmonary bypass
por: Elbers, PW, et al.
Publicado: (2010)

Continuous pulse contour analysis after cardiopulmonary bypass in cardiac surgery
por: Sander, M, et al.
Publicado: (2005)

Predictive genetic factors for bleeding in cardiac surgery patients with cardiopulmonary bypass
por: Iribarren Sarrias, J, et al.
Publicado: (2006)

Does cardiopulmonary bypass increase the risk of postoperative acute kidney injury after coronary artery bypass grafting?
por: Karmali, A, et al.
Publicado: (2015)

Acute Effect of Intravenous Administration of Magnesium Sulfate on Serum Levels of Interleukin-6 and Tumor Necrosis Factor-α in Patients Undergoing Elective Coronary Bypass Graft With Cardiopulmonary Bypass
por: Aryana, Parastou, et al.
Publicado: (2014)

Cardiopulmonary Bypass
por: Rondelez, Luc, et al.
Publicado: (2010)

The role of TLR4 and neutrophil expression in infection-triggered arthritis
por: Zhang, X, et al.
Publicado: (2004)

Is procalcitonin a valuable marker for identification of postoperative complications after coronary artery bypass graft surgery with cardiopulmonary bypass?
por: Baysal, A, et al.
Publicado: (2015)

Does the use of a cytokine 'filter' during cardiopulmonary bypass make sense?
por: Clermont, G, et al.
Publicado: (2004)

Cardiopulmonary bypass and recombinant plasminogen activator for treatment of experimental fatal pulmonary embolism
por: Kjærgaard, B, et al.
Publicado: (2007)

Do erythrocytes subjected to cardiopulmonary bypass exhibit changes in their membrane mechanical properties?
por: Clark, T, et al.
Publicado: (2013)

Dynamics of peripheral perfusion parameters in elective coronary artery bypass graft patients
por: Van Genderen, M, et al.
Publicado: (2011)

Does tranexamic acid decrease bleeding in patients undergoing cardiopulmonary bypass?
por: Connelly, N. R., et al.
Publicado: (1994)

Perioperative considerations in a sickle cell patient undergoing cardiopulmonary bypass
por: Raut, Monish S, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_osqulka20k83eqfo1koqmd8gk2